These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32506168)

  • 1. Metabolic heterogeneity and adaptability in brain tumors.
    Badr CE; Silver DJ; Siebzehnrubl FA; Deleyrolle LP
    Cell Mol Life Sci; 2020 Dec; 77(24):5101-5119. PubMed ID: 32506168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.
    Landis CJ; Tran AN; Scott SE; Griguer C; Hjelmeland AB
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):175-188. PubMed ID: 29378228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches.
    Shakya S; Gromovsky AD; Hale JS; Knudsen AM; Prager B; Wallace LC; Penalva LOF; Brown HA; Kristensen BW; Rich JN; Lathia JD; Brown JM; Hubert CG
    Acta Neuropathol Commun; 2021 May; 9(1):101. PubMed ID: 34059134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic regulation of glioma stem-like cells in the tumor micro-environment.
    Thomas TM; Yu JS
    Cancer Lett; 2017 Nov; 408():174-181. PubMed ID: 28743531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming therapeutic resistance in glioblastoma: the way forward.
    Osuka S; Van Meir EG
    J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy in glioblastoma: A mechanistic perspective.
    Meena D; Jha S
    Int J Cancer; 2024 Aug; 155(4):605-617. PubMed ID: 38716809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin.
    Romero-Reyes J; Vázquez-Martínez ER; Silva CC; Molina-Hernández A; Díaz NF; Camacho-Arroyo I
    Mol Biol Rep; 2024 Aug; 51(1):912. PubMed ID: 39153092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression.
    Lu IN; Dobersalske C; Rauschenbach L; Teuber-Hanselmann S; Steinbach A; Ullrich V; Prasad S; Blau T; Kebir S; Siveke JT; Becker JC; Sure U; Glas M; Scheffler B; Cima I
    Nat Commun; 2021 Jun; 12(1):3895. PubMed ID: 34162860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
    Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
    Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies targeting glioblastoma stem cells.
    Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
    Florio T; Barbieri F
    Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
    Piperi C; Papavassiliou KA; Papavassiliou AG
    Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling.
    Gimple RC; Kidwell RL; Kim LJY; Sun T; Gromovsky AD; Wu Q; Wolf M; Lv D; Bhargava S; Jiang L; Prager BC; Wang X; Ye Q; Zhu Z; Zhang G; Dong Z; Zhao L; Lee D; Bi J; Sloan AE; Mischel PS; Brown JM; Cang H; Huan T; Mack SC; Xie Q; Rich JN
    Cancer Discov; 2019 Sep; 9(9):1248-1267. PubMed ID: 31201181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma cancer stem cells--from concept to clinical application.
    Stopschinski BE; Beier CP; Beier D
    Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modulation of metabolism in glioblastoma.
    Dong Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
    Nakano I
    Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of cancer stem cell and tumorigenesis.
    Zhu K; Xie V; Huang S
    Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
    Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
    Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.